Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations
Year of publication: |
1999
|
---|---|
Authors: | Wisloff, Finn ; Gulbrandsen, Nina ; Nord, Erik |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 16.1999, 4, p. 329-341
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Reviews-on-treatment | Multiple-myeloma | Antineoplastics | Interferon-alpha | Stem-cell-transplant | Cost-analysis | Bone-marrow-transplant | Quality-of-life | Immunoglobulins | Epoetin-alfa | Bisphosphonates |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Marino, Patricia, (2003)
-
Pharmacoeconomic Considerations in Treating Patients With Acute Leukaemia
Jonsson, Viggo, (1999)
-
Uyl-de Groot, Carin A., (1999)
- More ...
-
Discounting future health benefits : the poverty of consistency arguments
Nord, Erik, (2011)
-
IQWiG methods : a response to two critiques
Caro, J. Jaime, (2010)
-
Qalys : is the value of treatment proportional to the size of the health gain?
Nord, Erik, (2010)
- More ...